63rd Annual Meeting of the Japanese Society of Neurology

Session information

Oral Session

[O-07] Oral Session 07

Wed. May 18, 2022 3:35 PM - 5:05 PM Room11 (Tokyo International Forum G Block 7F G701)

Chair:Yaeko Ichikawa(Department of Neurology, Kyorin University School of Medicine), Motoharu Kawai(Neuromuscular Center Yoshimizu Hospital)

Satoko Miyatake1,2, Kunihiro Yoshida3, Hiroshi Doi4, Yosuke Miyaji4, Naohisa Ueda5, Jun Tsuyuzaki6, Minori Kodaira7, Hiroyuki Onoue8, Hiromi Fukuda2,4, Masaki Okubo4, Hitaru Kishida5, Shigeru Koyano9, Tatsuya Takahashi10, Yoya Ono9,11, Kazuhiro Higashida10, Nobuaki Yoshikura11, Katsuhisa Ogata12, Takayoshi Shimohata11, Fumiaki Tanaka4, Naomichi Matsumoto2 (1.Clinical Genetics Department, Yokohama City University Hospital, Japan, 2.Department of Neurology, National Hospital Organization Yokohama Medical Center, 3.Department of Neurology, Gifu University Graduate School of Medicine, 4.Department of Neurology, National Hospital Organization Higashisaitama National Hospital, 5.Department of Human Genetics, Yokohama City University Graduate School of Medicine, Japan, 6.Division of Neurogenetics, Department of Brain Disease Research, Shinshu University School of Medicine, 7.Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, 8.Department of Neurology, Yokohama City University Medical Center, 9.Department of Neurology, Asama Nanroku Komoro Medical Center, 10.Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, 11.Department of Neurology, Dokkyo Medical University Saitama Medical Center, 12.Department of Neurology, Yokohama Minami Kyosai Hospital)

Hiromi Fukuda1,2, Takeshi Mizuguchi2, Daisuke Yamaguchi3, Satoko Miyatake2,4, Hiroshi Doi1, Keisuke Morihara1, Yuki Satake5, Jun Sone6,7, Tomoko Okamoto8, Yuji Takahashi8, Yasushi Yabuki9,10, Norifumi Shioda9,10, Naomichi Matsumoto2, Fumiaki Tanaka1 (1.Department of Neurology and Stroke Medicine, Yokohama City University, Japan, 2.Graduate School of Pharmaceutical Sciences, Kumamoto University, 3.Department of Human Genetics, Yokohama City University, Japan, 4.BITS Co., Ltd, 5.Clinical Genetics Department, Yokohama City University Hospital, 6.Department of Neurology, Nagoya University, 7.Institute for Medical Science of Aging, Aichi Medical University, 8.Department of Neurology, National Hospital Organization Suzuka National Hospital,, 9.Department of Neurology, National Center Hospital, National Center of Neurology and Psychiatry, 10.Department of Genomic Neurology, Institute of Molecular Embryology and Genetics (IMEG), Kumamoto University)

Tatsuhiko Sano1,2, Tetsuya Nagata1,2, Satoe Ebihara1,2, Kie Yoshida-tanaka1,2, Hideki Mochizuki3, Masato Hasegawa4, Takanori Yokota1,2 (1.Department of Neurology and Neurological Sciences, Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Japan, 2.Center for Brain Integration Research (CBIR), Tokyo Medical and Dental University (TMDU), Japan, 3.Department of Neurology, Osaka University Graduate School of Medicine, 4.Department of Neuropathology and Cell Biology, Tokyo Metropolitan Institute of Medical Science)

Yuka Hayashi1,2, Yoshihide Sehara1, Yoshio Sakiyama2, Ryota Watano1, Kenji Ohba1, Hiroaki Mizukami1 (1.Division of Genetic Therapeutics, Center for Molecular Medicine, Jichi Medical University, Japan, 2.Department of Neurology, Saitama Medical Center, Jichi Medical University, Japan)